Psychometric validation of the electronic chronic pain questions (eCPQ) in a primary care setting

References

• IOM. Institute of Medicine. Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education, and Research. The National Academies Collection: Reports funded by National Institutes of Health. Washington (DC): The National Academies Press, 2011
   Google Scholar
• Elzahaf RA, Tashani OA, Unsworth BA, Johnson MI. The prevalence of chronic pain with an analysis of countries with a Human Development Index less than 0.9: a systematic review without meta-analysis. Curr Med Res Opin 2012;28:1221-9
   PubMed Web of Science ®Google Scholar
• Gureje O, Von Korff M, Simon GE, Gater R. Persistent pain and well-being: a World Health Organization Study in Primary Care. JAMA 1998;280:147-51
   PubMed Web of Science ®Google Scholar
• Hardt J, Jacobsen C, Goldberg J, et al. Prevalence of chronic pain in a representative sample in the United States. Pain Med 2008;9:803-12
   PubMed Web of Science ®Google Scholar
• Johannes CB, Le TK, Zhou X, et al. The prevalence of chronic pain in United States adults: results of an Internet-based survey. J Pain 2010;11:1230-9
   PubMed Web of Science ®Google Scholar
• Tsang A, Von Korff M, Lee S, et al. Common chronic pain conditions in developed and developing countries: gender and age differences and comorbidity with depression-anxiety disorders. J Pain 2008;9:883-91
   PubMed Web of Science ®Google Scholar
• Nahin RL. Estimates of pain prevalence and severity in adults: United States, 2012. J Pain 2015;16:769-80
   PubMed Web of Science ®Google Scholar
• Henderson JV, Harrison CM, Britt HC, et al. Prevalence, causes, severity, impact, and management of chronic pain in Australian general practice patients. Pain Med 2013;14:1346-61
   PubMed Web of Science ®Google Scholar
• Elliott AM, Smith BH, Penny KI, et al. The epidemiology of chronic pain in the community. Lancet 1999;354:1248-52
   PubMed Web of Science ®Google Scholar
• Roth RS, Geisser ME, Williams DA. Interventional pain medicine: retreat from the biopsychosocial model of pain. Transl Behav Med 2012;2:106-16
   PubMed Web of Science ®Google Scholar
• Cheatle MD, Klocek JW, McLellan AT. Managing pain in high-risk patients within a patient-centered medical home. Transl Behav Med 2012;2:47-56
   PubMed Web of Science ®Google Scholar
• NIH. National Pain Strategy: A Comprehensive Population Health-Level Strategy for Pain. Bethesda, Maryland, US: National Institutes of Health, 2016 (updated 16 March 2016). Available at: https://iprcc.nih.gov/docs/HHSNational_Pain_Strategy.pdf [Last Accessed 8 August 2016]
   Google Scholar
• JC. Joint Commission. Facts about Pain Management. Oakbrook, IL, USA: The Joint Commission, 2015. Available at: http://www.jointcommission.org/pain_management/default.aspx [Last Accessed 8 August 2016]
   Google Scholar
• Stanos S, Brodsky M, Argoff C, et al. Rethinking chronic pain in a primary care setting. Post Med 2016;128:502-15
   PubMed Web of Science ®Google Scholar
• Reuben DB, Alvanzo AA, Ashikaga T, et al. National Institutes of Health Pathways to Prevention Workshop: the role of opioids in the treatment of chronic pain. Ann Intern Med 2015;162:295-300
   PubMed Web of Science ®Google Scholar
• JCI. Joint Commission International Accreditation Standards for Primary Care Centers, 1st edn. Oak Brook, IL, USA: Joint Commission International, 2008:27-103
   Google Scholar
• Turk DC, Dworkin RH, Allen RR, et al. Core outcome domains for chronic pain clinical trials: IMMPACT recommendations. Pain 2003;106:337-45
   PubMed Web of Science ®Google Scholar
• Turk DC, Dworkin RH, Revicki D, et al. Identifying important outcome domains for chronic pain clinical trials: an IMMPACT survey of people with pain. Pain 2008;137:276-85
   PubMed Web of Science ®Google Scholar
• Haroutiunian S, Donaldson G, Yu J, Lipman AG. Development and validation of shortened, restructured Treatment Outcomes in Pain Survey instrument (the S-TOPS) for assessment of individual pain patients’ health-related quality of life. Pain 2012;153:1593-601
   PubMed Web of Science ®Google Scholar
• Price C, Olukoga O, Williams A, Bottle A. National Pain Audit Final Report 2010–2012. London, UK: British Pain Society, 2012
   Google Scholar
• WHO. Scoping Document for WHO Treatment Guidelines on chronic non-malignant pain in adults. Geneva, Switzerland: World Health Organization (WHO), 2008
   Google Scholar
• CPAIN (Chronic Pain Impact Network). Multidimensional clinical patient profiler and data registry used to facilitate care for patients with chronic pain. The resource created Patient Profile Reports that were used to document multiple pain characteristics and interference of pain in a patient’s daily life – information that can help guide treatment decisions and monitor treatment effectiveness. Pfizer was a founding partner of this initiative, which has since been completed [Data on file. Pfizer Inc, New York, NY, USA]
   Google Scholar
• Portenoy R. Development and testing of a neuropathic pain screening questionnaire: ID Pain. Curr Med Res Opin 2006;22:1555-65
   PubMed Web of Science ®Google Scholar
• Brown KE, Swift I, Spark MJ. Pain severity cut‐points and analgesic use by community‐dwelling people for chronic pain. J Pharm Pract Res 2012;42:196-9
   Google Scholar
• Hoffman DL, Sadosky A, Dukes EM, Alvir J. How do changes in pain severity levels correspond to changes in health status and function in patients with painful diabetic peripheral neuropathy? Pain 2010;149:194-201
   PubMed Web of Science ®Google Scholar
• Jensen MP, Smith DG, Ehde DM, Robinsin LR. Pain site and the effects of amputation pain: further clarification of the meaning of mild, moderate, and severe pain. Pain 2001;91:317-22
   PubMed Web of Science ®Google Scholar
• Zelman DC, Dukes E, Brandenburg N, et al. Identification of cut-points for mild, moderate and severe pain due to diabetic peripheral neuropathy. Pain 2005;115:29-36
   PubMed Web of Science ®Google Scholar
• Clark ME, Gironda RJ, Young RW. Development and validation of the Pain Outcomes Questionnaire-VA. J Rehabil Res Dev 2003;40:381-95
   PubMed Web of Science ®Google Scholar
• McHorney CA, Ware JE Jr, Lu JR, Sherbourne CD. The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care 1994:40-66
   PubMed Web of Science ®Google Scholar
• McHorney CA, Ware JE Jr, Raczek AE. The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 1993:247-63
   PubMed Web of Science ®Google Scholar
• Ware J, John E, Sherbourne JE, Donald C. The MOS 36-item short-form health survey (SF-36): I. Conceptual framework and item selection. Med Care 1992:473-83
   PubMed Web of Science ®Google Scholar
• Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67:361-70
   PubMed Web of Science ®Google Scholar
• Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosom Res 2002;52:69-77
   PubMed Web of Science ®Google Scholar
• Spritzer KL, Hays RD. MOS Sleep Scale: a manual for use and scoring, version 1.0. Los Angeles, CA, USA: RAND, 2003
   Google Scholar
• Hauser W, Jung E, Erbsloh-Moller B, et al. Validation of the Fibromyalgia Survey Questionnaire within a cross-sectional survey. PLoS One 2012;7:e37504
   PubMed Web of Science ®Google Scholar
• Wolfe F, Clauw DJ, Fitzcharles MA, et al. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res (Hoboken) 2010;62:600-10
   PubMed Web of Science ®Google Scholar
• Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30:473-83
   PubMed Web of Science ®Google Scholar
• Wolfe F, Clauw DJ, Fitzcharles MA, et al. Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR Preliminary Diagnostic Criteria for Fibromyalgia. J Rheumatol 2011;38:1113-22
   PubMed Web of Science ®Google Scholar
• SAS Institute Inc. SAS/GRAPH 9.4 Reference, Second Edition. Cary, NC, USA: SAS Institute Inc., 2014
   Google Scholar
• Cappelleri JC. Patient-reported outcomes: measurement, implementation and interpretation. Boca Raton: CRC Press/Taylor & Francis Group, 2014
   Google Scholar
• Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol 2006;3:77-101
   Google Scholar
• Sloan JA, Aaronson N, Cappelleri JC, et al.; Clinical Significance Consensus Meeting Group. Assessing the clinical significance of single items relative to summated scores. Mayo Clin Proc 2002;77:479-87
   PubMed Web of Science ®Google Scholar
• Franklin GM; American Academy of N. Opioids for chronic noncancer pain: a position paper of the American Academy of Neurology. Neurology 2014;83:1277-84
   PubMed Web of Science ®Google Scholar
• Painter JT, Crofford LJ. Chronic opioid use in fibromyalgia syndrome: a clinical review. J Clin Rheumatol 2013;19:72-7
   PubMed Web of Science ®Google Scholar
• Phillips K, Clauw DJ. Central pain mechanisms in chronic pain states – maybe it is all in their head. Best Pract Res Clin Rheumatol 2011;25:141-54
   PubMed Web of Science ®Google Scholar